Characterization of the effect of a combinend therapie with dinitrochlorobenzene (DNCB) and dacarbacine (DTIC) in melanoma
Project management at the University of Würzburg:
Although a combined therapy with the contact allergen dinitrochlorobenzene (DNCB) and dacarbazine (DTIC) is quite efficient in the treatment of melanoma the working mechanism is still unknown. Therefore, after the model was transfered successfully into mouse, we want to scrutinize the mechanism responsable for the effect of this therapy.
Projekt period: from 05.1999 to 04.2002
Sonstige öffentliche Mittel